Clinical Trials Browser

Phase 2 × Newly Diagnosed Oligometastatic Prostate Cancer × apalutamide × Clear all

NCT03298087 2025-08-01

Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer

Phase 2 Completed

28 enrolled 10 charts

Newly Diagnosed Oligometastatic Prostate Cancer